Skip to main content
HRTX logo

HRTX · Heron Therapeutics, Inc. /De/ · Analyst Estimates

Track HRTX — free
$0.37 +0.02 (+6.99%)
Market Cap
$55.85M
Shares
189.85M
Volume · Oct 5 1.69M Avg daily vol (3M) 2.58M

Analyst Estimates

Compare analyst forecasts for Heron Therapeutics, Inc. /De/ across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 10:38 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.14
-0.13
-0.12
—
-0.09
-0.09
-0.09
-0.09
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
147700000
148250000
148800000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.12
-0.11
-0.1
—
0.0
0.0
0.0
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
145800000
145900000
146000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.03
-0.025
-0.02
—
-0.02
-0.02
-0.02
-0.02
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
37400000
37500000
37600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.03
-0.03
-0.03
—
-0.01
-0.01
-0.01
-0.01
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
37900000
38400000
38900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —
Key facts CIK 818033 CUSIP 427746102 13F (30d) 2 filings 2 filers Visit website Investor relations